stockrowApnimed, Inc. (APMD) vs Kura Oncology, Inc. (KURA)
- Apnimed, Inc. APMD 15.08 +6.50%
- Kura Oncology, Inc. KURA 7.22 +6.18%
Apnimed, Inc. and Kura Oncology, Inc. are both Biotechnology companies. Apnimed, Inc. and Kura Oncology, Inc. are of similar size ($604.9M and $589.5M). Kura Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Apnimed, Inc. trades at 0.8×. Apnimed, Inc. has the higher net margin (81.6% vs −384.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Apnimed, Inc. leads on 12 and Kura Oncology, Inc. on 2.
Valuation
Profitability
| Metric | APMD | KURA | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.53% | 99.35% | 68.51% |
| Operating margin | 19.88% | (411.90%) | 0.00% |
| Net margin | 81.56% | (384.30%) | 0.00% |
| Free cash flow margin | (71.50%) | (152.06%) | 0.00% |
| Return on equity | 0.00% | (167.71%) | (51.96%) |
| Return on assets | 0.00% | (46.73%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack